To confirm tumorigenic activities were not enriched in the CD45+CD19- cells, we repeated tumor xenotransplantation experiments using purified CD45+CD19+ cells and CD45+CD19- cells from LCL and Farage and observed similar results (Table S3; Fig. S2). The gene discussed is PTPRC; the disease is neoplasm.